alexa Multidrug Resistant Tuberculosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Multidrug Resistant Tuberculosis

Tuberculosis is the leading cause of death from a curable infectious disease. Globally more than 1.3 million people die of the disease every year. Nearly one third of the world’s population is infected with tubercle bacilli; approximately 10% of them have a life time risk of developing the disease. The incidence rate is highest among young adults, and most cases are due to recent infection or reinfection. As transmission falls, the caseload shifts to older adults, and a higher proportion of cases are attributable to the reactivation of latent infection. The emergence of drug resistant TB, and particularly MDR-TB, has become a significant public health problem in a number of countries and an obstacle to effective TB control.


Citation: Therese KL. (2014) A Pilot Study on the Detection of Multidrug Resistant Tuberculosis in Hospital Based Population of Chennai, India.J Med Microb Diagn 3:153

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger